Author:
Venkataraman Karthik,Salehi Tania,Carroll Robert P.
Reference71 articles.
1. Enhancement of antitumor immunity by CTLA-4 blockade;Leach;Science,1996
2. Nivolumab plus ipilimumab in patients with advanced melanoma: updated survival, response, and safety data in a phase I dose-escalation study;Callahan;J Clin Oncol,2018
3. Immunotherapy in colorectal cancer: available clinical evidence, challenges and novel approaches;Tintelnot;World J Gastroenterol,2019
4. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial;El-Khoueiry;Lancet,2017
5. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N Engl J Med,2015